B2Gold Corp. (TSX:BTO)

Ligand Pharmaceuticals Revenue

B2Gold had revenue of $692.21M USD in the quarter ending June 30, 2025, with 40.53% growth. This brings the company's revenue in the last twelve months to $2.17B, up 11.75% year-over-year. In the year 2024, B2Gold had annual revenue of $1.90B, down -1.67%.

• Revenue (ttm): $2.17B
• Revenue Growth: +11.75%
• P/S Ratio: 2.32
• Revenue / Employee: $982.07K
• Employees: 2,212
• Market Cap: 6.87B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.90B	-32.24M	-1.67%
Dec 31, 2023	1.93B	201.68M	11.64%
Dec 31, 2022	1.73B	-29.67M	-1.68%
Dec 31, 2021	1.76B	-26.66M	-1.49%
Dec 31, 2020	1.79B	633.29M	54.80%